11/08/2026
【The Division of Urology introduces latest-generation adjustable continence therapy for post-prostatectomy incontinence
泌尿外科引入新一代尿道壓力調節技術 改善前列腺癌術後尿失禁】
We are proud to celebrate a major milestone achieved by the Division of Urology at HKU Surgery and Queen Mary Hospital.
Since the introduction of the latest-generation Adjustable Transobturator Male System in late 2024, our team has successfully treated more than 15 patients experiencing urinary incontinence following prostate cancer surgery, making Queen Mary Hospital the first centre in Asia to adopt this advanced technique.
Prostate cancer is one of the most common cancers among men in Hong Kong. While radical prostatectomy offers effective treatment, post-operative urinary incontinence can significantly affect patients’ daily activities, emotional well-being, and quality of life.
This minimally invasive device provides a personalised treatment solution. Dr. Ada Ng (Division Chief of Urology, Honorary Clinical Associate Professor) explained that the system enables surgeons to fine-tune urethral pressure after surgery through a simple outpatient adjustment, eliminating the need for further surgical intervention. Dr. Thomas Wong (Resident Specialist, Honorary Clinical Tutor) added that the technology offers a safe, effective, and reliable alternative to existing surgical options, helping patients regain continence, confidence, dignity, and quality of life.
A heartfelt thank you to our multidisciplinary clinical team, surgeons, anaesthetists, nursing staff, and all colleagues who contributed to making this achievement possible. Together, we will continue advancing urological care and improving patient outcomes in Hong Kong.
港大外科暨瑪麗醫院泌尿外科團隊自2024年底引入新一代「尿道壓力調節裝置」以來,已成功為超過15名接受前列腺癌手術後出現尿失禁的患者提供治療服務,並成為亞洲首個採用此項先進技術的醫療中心。
前列腺癌是本港男性最常見的癌症之一。雖然根治性切除手術能有效治療疾病,但術後尿失禁問題往往對患者的日常生活、心理健康及生活質素造成深遠影響。
作為一項微創治療技術,此裝置能為患者提供更個人化的治療方案。泌尿外科主管兼港大外科名譽臨床副教授吳翠蓮醫生表示,醫療團隊可於門診透過簡單程序,因應患者情況調節尿道壓力,無須再次接受手術。泌尿外科專科駐院醫生兼港大外科名譽臨床導師王庭峰醫生指出,該技術為患者提供安全、有效而可靠的治療選擇,協助他們重拾控尿能力、自信、尊嚴及生活質素。
衷心感謝跨專業臨床團隊、外科團隊、麻醉科團隊及護理團隊的專業付出與協作。讓我們繼續攜手推動香港泌尿外科醫療及臨床服務發展,為病人帶來更優質的治療成果。